|
-
The first FFDM system introduced on the market in 1999.
-
An installed base of more than 1000 systems worldwide.
-
Used in the two largest screening trials showing digital versus analog benefits (Oslo II; DMIST – ACRIN).
-
More than 300 scientific studies stressing Senographe 2000D’s technical performance.
|
|
-
Unique bi-metal mammography tube with a rhodium anode for a superior penetration of dense breast tissues at a lower dose.
-
Revolution detector’s single-piece structure (Cesium-Csi) for full image quality and reliability without the risk of artifacts.
-
Exclusive Automatic Optimization of Parameters (AOP) automatically fine-tuning parameters depending on breast density.
-
Whatever breast density: consistency of image quality and fewer patients recalls.
-
Premium View and Fine View image treatment enhancing overall contrast and visibility of micro calcifications.
-
Premium View available on Seno Advantage 2.1. or at acquisition.
|
|
-
Dose optimization thanks to AOP, rhodium track anode and GE’s detector technology.
-
Consistency of image quality, fewer retakes and complementary views for a total lower dose the patient.
-
DMIST study - 49,000 women in 33 sites imaged - demonstrated a 28% dose reduction for Senographe 2000D versus screening film.
-
DMIST study awarded Senographe 2000D for dose optimization versus other systems involved in the study.
|
|
-
Very fast acquisition and availability for diagnostic: 60% time reduction regarding screen film.
-
Images taken within a second and displayed on the acquisition workstation a few seconds later for an accrued workflow efficiency.
-
Optimized image size (only 9Mb) for data transfer and archiving benefits.
|
|
-
GE’s controls the manufacturing process of all image chain components (tube, detector, review station) from A to Z in order to ensure a top of range quality and reliability.
-
GE’s digital detector built with a Cesium lodine detector (Csi) guarantees over the years Senographe 2000D’s stability even under intense workflow conditions.
|
|
